GREGG A. LAPOINTE, C.P.A.

Corporate Board Profile

Tech Score: 0/100

SOLIGENIX, INC.

Filing Date	Source Excerpt
2012-05-11	Gregg Lapointe, C.P.A. has been a director since March 2009. Mr. Lapointe has served on the Board of Directors of the Pharmaceuticals Research and Manufacturers of America and SciClone Pharmaceuticals, Inc., and has been a member of the Corporate Council of NORD for several years. The Nominating and Corporate Governance Committee is comprised of Mr. Lapointe (Chair), Ms. Howson and Dr. Zeldis. The following table contains information concerning the compensation of the non-employee directors during the fiscal year ended December 31, 2011. Gregg A. Lapointe Fees Earned Paid in Cash $26,497, Option Awards $30,001, Total $56,498.

Filing Date

Source Excerpt

2012-05-11

Gregg Lapointe, C.P.A. has been a director since March 2009. Mr. Lapointe has served on the Board of Directors of the Pharmaceuticals Research and Manufacturers of America and SciClone Pharmaceuticals, Inc., and has been a member of the Corporate Council of NORD for several years. The Nominating and Corporate Governance Committee is comprised of Mr. Lapointe (Chair), Ms. Howson and Dr. Zeldis. The following table contains information concerning the compensation of the non-employee directors during the fiscal year ended December 31, 2011. Gregg A. Lapointe Fees Earned Paid in Cash $26,497, Option Awards $30,001, Total $56,498.

Data sourced from SEC filings. Last updated: 2025-12-07